Reply Re: "Teprotumumab for the Treatment of Recalcitrant Thyroid Eye Disease"

Ophthalmic Plast Reconstr Surg. 2025 Jan-Feb;41(1):111-112. doi: 10.1097/IOP.0000000000002875. Epub 2025 Jan 3.
No abstract available